118 related articles for article (PubMed ID: 24391072)
1. [Immunopathogenesis of idiopathic pulmonary fibrosis].
Demkow U
Pneumonol Alergol Pol; 2014; 82(1):55-60. PubMed ID: 24391072
[TBL] [Abstract][Full Text] [Related]
2. Epithelium-dependent profibrotic milieu in the pathogenesis of idiopathic pulmonary fibrosis: current status and future directions.
Xu X; Dai H; Wang C
Clin Respir J; 2016 Mar; 10(2):133-41. PubMed ID: 25047066
[TBL] [Abstract][Full Text] [Related]
3. Permanent alveolar collapse is the predominant mechanism in idiopathic pulmonary fibrosis.
Todd NW; Atamas SP; Luzina IG; Galvin JR
Expert Rev Respir Med; 2015 Aug; 9(4):411-8. PubMed ID: 26165208
[TBL] [Abstract][Full Text] [Related]
4. Pathogenesis of idiopathic pulmonary fibrosis: from initial apoptosis of epithelial cells to lung remodeling?
Jin HL; Dong JC
Chin Med J (Engl); 2011 Dec; 124(24):4330-8. PubMed ID: 22340409
[TBL] [Abstract][Full Text] [Related]
5. CCR10+ epithelial cells from idiopathic pulmonary fibrosis lungs drive remodeling.
Habiel DM; Espindola MS; Jones IC; Coelho AL; Stripp B; Hogaboam CM
JCI Insight; 2018 Aug; 3(16):. PubMed ID: 30135312
[TBL] [Abstract][Full Text] [Related]
6. Premature lung aging and cellular senescence in the pathogenesis of idiopathic pulmonary fibrosis and COPD/emphysema.
Chilosi M; Carloni A; Rossi A; Poletti V
Transl Res; 2013 Sep; 162(3):156-73. PubMed ID: 23831269
[TBL] [Abstract][Full Text] [Related]
7. Revealing the pathogenic and aging-related mechanisms of the enigmatic idiopathic pulmonary fibrosis. an integral model.
Selman M; Pardo A
Am J Respir Crit Care Med; 2014 May; 189(10):1161-72. PubMed ID: 24641682
[TBL] [Abstract][Full Text] [Related]
8. Danger-associated molecular patterns and danger signals in idiopathic pulmonary fibrosis.
Ellson CD; Dunmore R; Hogaboam CM; Sleeman MA; Murray LA
Am J Respir Cell Mol Biol; 2014 Aug; 51(2):163-8. PubMed ID: 24749648
[TBL] [Abstract][Full Text] [Related]
9. Tissue remodelling in pulmonary fibrosis.
Knudsen L; Ruppert C; Ochs M
Cell Tissue Res; 2017 Mar; 367(3):607-626. PubMed ID: 27981380
[TBL] [Abstract][Full Text] [Related]
10. Macrophages: friend or foe in idiopathic pulmonary fibrosis?
Zhang L; Wang Y; Wu G; Xiong W; Gu W; Wang CY
Respir Res; 2018 Sep; 19(1):170. PubMed ID: 30189872
[TBL] [Abstract][Full Text] [Related]
11. Angiostatic versus angiogenic chemokines in IPF and EAA.
Martina S; Martina V; Monika M; Jan P; Libor K; Ilja S
Respir Med; 2009 Nov; 103(11):1651-6. PubMed ID: 19535235
[TBL] [Abstract][Full Text] [Related]
12. IPF: new insight on pathogenesis and treatment.
Harari S; Caminati A
Allergy; 2010 May; 65(5):537-53. PubMed ID: 20121758
[TBL] [Abstract][Full Text] [Related]
13. Idiopathic pulmonary fibrosis: evolving concepts.
Ryu JH; Moua T; Daniels CE; Hartman TE; Yi ES; Utz JP; Limper AH
Mayo Clin Proc; 2014 Aug; 89(8):1130-42. PubMed ID: 24867394
[TBL] [Abstract][Full Text] [Related]
14. Mast cell chymase: an indispensable instrument in the pathological symphony of idiopathic pulmonary fibrosis?
Kosanovic D; Dahal BK; Wygrecka M; Reiss I; Günther A; Ghofrani HA; Weissmann N; Grimminger F; Seeger W; Schermuly RT; Banat GA
Histol Histopathol; 2013 Jun; 28(6):691-9. PubMed ID: 23436625
[TBL] [Abstract][Full Text] [Related]
15. Detection and quantification of epithelial progenitor cell populations in human healthy and IPF lungs.
Smirnova NF; Schamberger AC; Nayakanti S; Hatz R; Behr J; Eickelberg O
Respir Res; 2016 Jul; 17(1):83. PubMed ID: 27423691
[TBL] [Abstract][Full Text] [Related]
16. Influences of innate immunity, autophagy, and fibroblast activation in the pathogenesis of lung fibrosis.
O'Dwyer DN; Ashley SL; Moore BB
Am J Physiol Lung Cell Mol Physiol; 2016 Sep; 311(3):L590-601. PubMed ID: 27474089
[TBL] [Abstract][Full Text] [Related]
17. The Epithelial-Immune Crosstalk in Pulmonary Fibrosis.
Planté-Bordeneuve T; Pilette C; Froidure A
Front Immunol; 2021; 12():631235. PubMed ID: 34093523
[TBL] [Abstract][Full Text] [Related]
18. Idiopathic pulmonary fibrosis-an epidemiological and pathological review.
Borchers AT; Chang C; Keen CL; Gershwin ME
Clin Rev Allergy Immunol; 2011 Apr; 40(2):117-34. PubMed ID: 20838937
[TBL] [Abstract][Full Text] [Related]
19. Pirfenidone: antifibrotic agent for idiopathic pulmonary fibrosis.
Azuma A
Expert Rev Respir Med; 2010 Jun; 4(3):301-10. PubMed ID: 20524912
[TBL] [Abstract][Full Text] [Related]
20. Idiopathic pulmonary fibrosis may be a disease of recurrent, tractional injury to the periphery of the aging lung: a unifying hypothesis regarding etiology and pathogenesis.
Leslie KO
Arch Pathol Lab Med; 2012 Jun; 136(6):591-600. PubMed ID: 22136526
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
